Global Transplant Diagnostics Market size is projected to be valued $XX Billion by 2024; with a CAGR of XX% from 2017 to 2025. Transplantation is the process of relocating organ in order to treat organ failure such as lungs, heart, pancreas, liver and kidney. HLA diagnostic testing is accomplished to determine the tissue compatibility between the donor and recipient in organ and bone marrow transplant.
Major driving factors for this market are raising incidence of chronic diseases, increasing aged population, number of organ transplant procedures, technological advancements and increased R&D activities. However, lack of awareness and organ shortage for transplant procedures are witnessing the growth of the market. Increasing need for organ transplants and growing burden of chronic diseases in emerging nations are creating future opportunities for the transplant diagnostics market.
The transplant diagnostics market is segmented into end user, technology, organ type, application, screening type and geography. On the basis of end user, the transplant diagnostics market is segmented into research laboratories and academic institutions, hospitals and transplant centers and commercial service providers. By organ type, the market is segmented into liver, kidney, heart, pancreas, lung and others. On the basis of technology, transplant diagnostics market is segmented into molecular assay, non-molecular assay and sequencing-based. Furthermore, by screening type the market is segmented into pre-transplant Screening and post-transplant Screening. On the basis of application this market is segmented into research applications and diagnostic applications.
By geography the market is segmented into North America, Europe, Asia-Pacific and RoW. The U.S., Mexico and Canada are covered under North America wherein Europe covers France, Germany, UK, Spain and rest of Europe. Asia-Pacific covers China, India, Japan, South Korea and Rest of Asia Pacific. Rest of the World (RoW) covers South America, Middle East and Africa.
Major players for Transplant diagnostics market are Abbott Laboratories Inc., Qiagen N.V., Illumina, Inc., Linkage Biosciences, Immucor Inc., OlerupSspAb, Thermo Fisher Scientific Inc., Bio- F. Hoffmann-La Roche, Ltd., Sigma-Aldrich, and Rad Laboratories Inc. including others.
The report covers
Scope of the Global Transplant Diagnostics Market
Organ Type Segments
Screening Type Segments
End User Segments